Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [619]
News [1052]
Articles [54]
Editorials [2]
Conferences [97]
elearning [5]
Celebrating a 10 year partnership: ecancer and the IEO
Prof Gordon McVie - Editor in Chief, ecancer
Celebrating a 10 year partnership: ecancer and the IEO ( Prof Gordon McVie - Editor in Chief, ecancer )
19 Jul 2017
ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year
Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy
ShortHER trastuzumab treatment of HER2 breast cancer: 9 weeks v 1 year ( Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy )
5 Jun 2017
Halving duration of ADT for high risk prostate cancer patients
Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada
Halving duration of ADT for high risk prostate cancer patients ( Prof Abdenour Nabid - Sherbrooke University Hospital Centre, Sherbrooke, Canada )
4 Jun 2017
Delaying metastatic prostate cancer, improving survival with abiraterone
Prof Karim Fizazi - Institut Gustave Roussy, Paris, France
Delaying metastatic prostate cancer, improving survival with abiraterone ( Prof Karim Fizazi - Institut Gustave Roussy, Paris, France )
3 Jun 2017
STAMPEDE trial: abiraterone for advanced prostate cancer reduces progression...
Prof Nick James - Queen Elizabeth Hospital Birmingham & University of...
STAMPEDE trial: abiraterone for advanced prostate cancer reduces progression/deaths ( Prof Nick James - Queen Elizabeth Hospital Birmingham & University of Birmingham, UK )
3 Jun 2017
Transforming patient care through translational research
Prof Aleix Prat - Hospital Clinic of Barcelona, Barcelona, Spain
Transforming patient care through translational research ( Prof Aleix Prat - Hospital Clinic of Barcelona, Barcelona, Spain )
12 May 2017
Increased long-term risk of breast cancer with high intra-tumour ER hetrogeneity
Dr Linda Lindström - University of California at San Francisco, San Francisco...
Increased long-term risk of breast cancer with high intra-tumour ER hetrogeneity ( Dr Linda Lindström - University of California at San Francisco, San Francisco, USA )
12 May 2017
GTX-024 for androgen receptor positive breast cancer
Prof Beth Overmoyer - Dana-Farber Cancer Institute, Boston, USA
GTX-024 for androgen receptor positive breast cancer ( Prof Beth Overmoyer - Dana-Farber Cancer Institute, Boston, USA )
12 May 2017
Final overall survival analysis of MONARCH 1
Dr Hope Rugo - UCSF Medical Center, San Francisco, USA
Final overall survival analysis of MONARCH 1 ( Dr Hope Rugo - UCSF Medical Center, San Francisco, USA )
11 Apr 2017
Redefining tamoxifen for breast cancer
Gokul Das - Roswell Park Cancer Institute, Buffalo, USA
Redefining tamoxifen for breast cancer ( Gokul Das - Roswell Park Cancer Institute, Buffalo, USA )
11 Apr 2017
Final results of the HERACLES trial in HER2-amplified colorectal cancer
Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy
Final results of the HERACLES trial in HER2-amplified colorectal cancer ( Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy )
10 Apr 2017
Treatment choices for HER2 amplified colorectal cancer
Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy
Treatment choices for HER2 amplified colorectal cancer ( Dr Silvia Marsoni - Candiolo Cancer Institute, Turin, Italy )
10 Apr 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation